Fig. 2From: A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s diseaseHistogram showing the distribution of median estimated age at onset of clinical sporadic Alzheimer’s disease (sAD) in all patients with MCI or sAD (A) and the corresponding distribution of chronological age (B)Back to article page